AT193451T
Verotoxin pharmaceutical compositions and medical treatments therewith
Abstract
(57) As for ベロトキシン of summary known, and the medicine composite containing especially ベロトキシン 1, tumor being formation of a mammal and having been useful to the disposal of an ovarian cancer and skin cancer especially were admitted. Although it was shown in the surprising thing that ベロトキシン 1 has tumorigenic suppression activity out of a living body conventionally, ベロトキシン 1 of the non-fatality given dose showed the effect which controls tumor formation therapeutically in the living body.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
53 members in 10 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 2116179 | Canada | A | |
| 9500085 | Canada | W |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| CA2116179A1 | Canada | A1 | |
| WO9522349A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1703195A | Australia | A | |
| EP0746337A1 | European Patent Office (EPO) | A1 | |
| JPH10500103A | Japan | A | |
| AU701100B2 | Australia | B2 | |
| US5968894A | United States of America | A | |
| NZ331165A | New Zealand | A | |
| EP0746337B1 | European Patent Office (EPO) | B1 | |
| AT193451TThis record | Austria | T | |
| ATE193451T1 | Austria | T1 | |
| DE69517302D1 | Germany | D1 | |
| ES2149347T3 | Spain | T3 | |
| DE69517302T2 | Germany | T2 | |
| US6228370B1 | United States of America | B1 | |
| US6835710B1 | United States of America | B1 | |
| US2005130895A1 | United States of America | A1 | |
| US7208468B2 | United States of America | B2 | |
| US2007160535A1 | United States of America | A1 | |
| CA2116179C | Canada | C | |
| US2008112525A1 | United States of America | A1 | |
| US2008224735A1 | United States of America | A1 | |
| US2008225989A1 | United States of America | A1 | |
| US2008304610A1 | United States of America | A1 | |
| US2009092213A1 | United States of America | A1 | |
| US2009147901A1 | United States of America | A1 | |
| US2009147904A1 | United States of America | A1 | |
| US2009157791A1 | United States of America | A1 | |
| US2009167374A1 | United States of America | A1 | |
| US2009172070A1 | United States of America | A1 | |
| US7560426B2 | United States of America | B2 | |
| US2009201066A1 | United States of America | A1 | |
| US2009279653A1 | United States of America | A1 | |
| US2009296867A1 | United States of America | A1 | |
| US7720189B2 | United States of America | B2 | |
| US7730650B1 | United States of America | B1 | |
| US7778371B2 | United States of America | B2 | |
| US7813466B2 | United States of America | B2 | |
| US7826563B2 | United States of America | B2 | |
| US8059778B1 | United States of America | B1 | |
| US8094754B2 | United States of America | B2 | |
| US8111785B2 | United States of America | B2 | |
| US8121242B2 | United States of America | B2 | |
| US8175207B2 | United States of America | B2 | |
| US8180011B2 | United States of America | B2 | |
| US8180012B1 | United States of America | B1 | |
| US8346840B2 | United States of America | B2 | |
| US8406365B2 | United States of America | B2 | |
| US8443023B2 | United States of America | B2 | |
| US8478805B1 | United States of America | B1 | |
| US8489664B2 | United States of America | B2 | |
| US8554815B1 | United States of America | B1 | |
| US8762436B1 | United States of America | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 95908853
Titles2
- German
- VEROTOXIN PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND DAMIT MEDIZINISCHE BEHANDLUNGEN
- English
- VEROTOXIN PHARMACEUTICAL COMPOSITIONS AND THEREFOR MEDICAL TREATMENTS
Classification
- CPC, 3
- A61K38/164
- C07K14/245
- A61P35/00
- IPC, 4
- A61K38 00
- A61K38 16
- A61P35 00
- C07K14 245